MacroGenics
MGNX
#8653
Rank
ยฃ0.17 B
Marketcap
ยฃ2.77
Share price
-7.73%
Change (1 day)
122.94%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : ยฃ15.87 Million

According to MacroGenics's latest financial reports the company has ยฃ15.87 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ41.27 M-55.37%
2024-12-31$ยฃ92.48 M-22.8%
2023-12-31$ยฃ0.11 B2.05%
2022-12-31$ยฃ0.11 B-33.87%
2021-12-31$ยฃ0.17 B-18.22%
2020-12-31$ยฃ0.21 B23.42%
2019-12-31$ยฃ0.17 B-8.08%
2018-12-31$ยฃ0.19 B-13.58%
2017-12-31$ยฃ0.22 B1.66%
2016-12-31$ยฃ0.21 B3.01%
2015-12-31$ยฃ0.21 B171.42%
2014-12-31$ยฃ77.9 M62.84%
2013-12-31$ยฃ47.84 M-1038.71%
2012-12-31$-ยฃ5.1 Million-54.69%
2011-12-31$-ยฃ11.25 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
ยฃ67.68 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.35 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.88 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ17.54 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ34.38 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ15.04 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.38 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA